Skip to main content

Table 1 Demographic and clinical characteristics of 82 confirmed H7N9 patients

From: Efficacy of oseltamivir-peramivir combination therapy compared to oseltamivir monotherapy for Influenza A (H7N9) infection: a retrospective study

Characteristic

No. of cases (%)

P value*

 

Total (n = 82)

The first wave (n = 39)

The second wave (n = 43)

 

Male patients

56 (68.29)

   

Age (years)

 18–49

19(23.17)

8(20.51)

11(25.58)

0.09

 50–64

35(42.68)

13(33.33)

22(51.16)

 ≥65

28(34.15)

18(46.15)

10(23.26)

Coexisting condition

 Any

44(53.66)

23(84.62)

21(48.84)

0.38

 Hypertension

38(46.34)

   

 Diabetes

17(20.73)

 Coronary heart disease

6(7.31)

 Cerebrovascular disease

4(4.86)

 Chronic obstructive pulmonary disease

3(3.65)

 Cancersa

2(2.43)

 Immunosuppressionb

2(2.43)

 Hepatitis B infection

1(1.22)

 Pregnancy

1(1.22)

Symptoms

 

 Fever

82(100)

 Cough

73(89.02)

 Sputum production

52(63.41)

 Shortness of breath

52(63.41)

 Fatigue/weekness

32(39.02)

 Hemoptysis

17(20.73)

 Gastrointestinal symptomc

11(3.41)

  1. aCancers included leukemia and lymphoma
  2. bImmunosuppression caused by the immunosuppressive drug after renal transplantation
  3. cGastrointestinal symptom included nausea, vomiting, diarrhea, and abdominal pain
  4. *The p value was calculated between the first and second H7N9 wave